Patent directory · USPTO A61K / A61P
Patents matching “THE UNITED STATES OF AMERICA, as represented by th”
2,147 pharma patents match "THE UNITED STATES OF AMERICA, as represented by th" in our USPTO index (A61K/A61P) — applicant, grant date, expiration, and drug links.
Quick answer
This filtered view shows 2,147 pharmaceutical patents matching "THE UNITED STATES OF AMERICA, as represented by th" in our USPTO PatentsView index (CPC A61K/A61P). Search matches patent number, title, applicant, and CPC classification codes.
Patent results
-
US 8636978
Cyclized NGR peptide compounds, compositions, and methods of their use
granted -
US 8637050
Peptide vaccines against group A streptococci
granted -
US 8637049
Attenuated live vaccines for aquatic animals
granted -
US 8633177
Nitroxyl (HNO) releasing compounds and uses thereof in treating diseases
granted -
US 8632782
Recombinant attenuated dengue viruses comprising mutations in NS5 and the 3′ untranslated region
granted -
US 8628962
Differentiation of stem cells into dopaminergic cells
granted -
US 8628764
Biocontrol of storage maladies of potatoes by bacterial antagonists produced in co-culture
granted -
US 8628782
Deletion of the beta 20-21 loop in HIV gp120 exposes the CD4 binding site for improved antibody binding and antibody induction
granted -
US 8618090
Inhibitors of the plasmodial surface anion channel as antimalarials
granted -
US 8613932
GP100-specific T cell receptors and related materials and methods of use
granted -
US 8614304
Immunogenic peptides and methods of use for treating and preventing cancer
granted -
US 8613934
Cellular and viral inactivation
granted -
US 8613933
Brachyury polypeptides and methods for use
granted -
US 8609395
Agonist and antagonist peptides of carcinoembryonic antigen (CEA)
granted -
US 8609716
Chondropsin-class antitumor V-ATPase inhibitor compounds, compositions and methods of use thereof
granted -
US 8603978
Use of muramyl dipeptide (MDP) for treating inflammation
granted -
US 8597660
Therapeutic approach to neurodegenerative disorders using a TFP5-peptide
granted -
US 8597876
Method of treating HIV infection
granted -
US 8597883
Biomarkers for cancer-related fatigue and use thereof
granted -
US 8580927
Engineered antibody constant domain molecules
granted -
US 8574853
Monoclonal antibodies that neutralize anthrax toxins
granted -
US 8575375
Androstane and pregnane steroids with potent allosteric GABA receptor chloride ionophore modulating properties
granted -
US 8569028
Method for encapsulation of microparticles
granted -
US 8568739
Antigenic chimeric tick-borne encephalitis virus/dengue virus type 4 recombinant viruses
granted